Abstract
The natural biological function of the skin is to protect the body against harmful infections by hindering the intrusion of foreign pathogens. In terms of protection, the skin serves a dual functionality: the physical barrier provided by the stratum corneum and the immunological barrier stimulated by the antigen-presenting cells (APCs) in the dermis and epidermis. In recent years, several findings have established that stimulating the APCs underneath the stratum corneum can provide several advantages in terms of vaccine administration over conventional methods. Hence, such “intradermal immunization” methods have been investigated worldwide. As a result, some of the intradermal vaccine delivery methods that were developed include the Mantoux technique, ballistic vaccination, epidermal powder immunization (EPI), jet injector, tattoo immunization, and microneedles. This chapter attempts to briefly delineate these methods and describe the state of research regarding these technologies in the present day.
References
Aguiar JC, Hedstrom RC et al (2001) Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device. Vaccine 20(1–2):275–280
Alarcon JB, Hartley AW et al (2007) Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 14(4):375–381
Arnou R, Icardi G et al (2009) Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine 27(52):7304–7312
Arora A, Hakim I et al (2007) Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets. Proc Natl Acad Sci U S A 104(11):4255–4260
Baxter J, Mitragotri S (2005) Jet-induced skin puncture and its impact on needle-free jet injections: experimental studies and a predictive model. J Control Release 106(3):361–373
Belshe RB (2004) Current status of live attenuated influenza virus vaccine in the US. Virus Res 103(1–2):177–185
Beran J, Ambrozaitis A et al (2009) Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med 7(1):13
Bernard KW, Mallonee J et al (1987) Preexposure immunization with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination. JAMA 257(8):1059–1063
Bins AD, Jorritsma A et al (2005) A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 11(8):899–904
Boudreau EF, Josleyn M et al (2012) A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome. Vaccine 30(11):1951–1958
Chen DX, Payne LG (2002) Targeting epidermal Langerhans cells by epidermal powder immunization. Cell Res 12(2):97–104
Chen DX, Endres RL et al (2000) Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza vaccine and protection in mice. Nat Med 6(10):1187–1190
Chen DX, Periwal SB et al (2001a) Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization. J Virol 75(17):7956–7965
Chen DX, Weis KF et al (2001b) Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses. J Virol 75(23):11630–11640
Chen D, Zuleger C et al (2002a) Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses. AIDS Res Hum Retroviruses 18(10):715–722
Chen DX, Endres RL et al (2002b) Epidermal powder immunization using non-toxic bacterial enterotoxin adjuvants with influenza vaccine augments protective immunity. Vaccine 20(21–22):2671–2679
Chen D, Endres R et al (2003) Epidermal powder immunization of mice and monkeys with an influenza vaccine. Vaccine 21(21–22):2830–2836
Chen DX, Burger M et al (2004) Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity. Virus Res 103(1–2):147–153
Chen JS, Lin LP et al (2012) Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids. Microbiol Immunol 56(2):85–92
Chen MC, Huang SF et al (2013) Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination. Biomaterials 34(12):3077–3086
Chiu Y-N, Sampson JM et al (2012) Skin tattooing as a novel approach for DNA vaccine delivery. J Vis Exp 68:e50032
Dean HJ, Chen DX (2004) Epidermal powder immunization against influenza. Vaccine 23(5):681–686
Dean CH, Alarcon JB et al (2005) Cutaneous delivery of a live, attenuated chimeric flavivirus vaccines against Japanese encephalitis (ChimeriVaxTM-JE) in non-human primates. Hum Vaccin 1(3):106–111
Debenedictis C, Joubeh S et al (2001) Immune functions of the skin. Clin Dermatol 19(5):573–585
Ding Z, Van Riet E et al (2009a) Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment. Pharm Res 26(7):1635–1643
Ding Z, Verbaan FJ et al (2009b) Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. J Control Release 136(1):71–78
Epstein JE, Gorak EJ et al (2002) Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes. Hum Gene Ther 13(13):1551–1560
Eriksson E, Yao F et al (1998) In vivo gene transfer to skin and wound by microseeding. J Surg Res 78(2):85–91
Feltquate DM, Heaney S et al (1997) Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158(5):2278–2284
Foege WH, Millar JD et al (1971) Selective epidemiologic control in smallpox eradication. Am J Epidemiol 94(4):311–315
Fynan EF, Webster RG et al (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 90(24):11478–11482
Giudice EL, Campbell JD (2006) Needle-free vaccine delivery. Adv Drug Deliv Rev 58(1):68–89
Gopee NV, Cui YY et al (2005) Response of mouse skin to tattooing: use of SKH-1 mice as a surrogate model for human tattooing. Toxicol Appl Pharmacol 209(2):145–158
Gorres JP, Lager KM et al (2011) DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs. Clin Vaccine Immunol 18(11):1987–1995
Haensler J, Verdelet C et al (1999) Intradermal DNA immunization by using jet-injectors in mice and monkeys. Vaccine 17(7–8):628–638
Hirobe S, Azukizawa H et al (2015) Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials 57:50–58
Holland D, Booy R et al (2008) Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 198(5):650–658
Huang HN, Li TL et al (2009a) Transdermal immunization with low-pressure-gene-gun mediated chitosan-based DNA vaccines against Japanese encephalitis virus. Biomaterials 30(30):6017–6025
Huang J, D’Souza AJ et al (2009b) Protective immunity in mice achieved with dry powder formulation and alternative delivery of plague F1-V vaccine. Clin Vaccine Immunol 16(5):719–725
Jackson LA, Austin G et al (2001) Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 19(32):4703–4709
Joseph SK, Sambanthamoorthy S et al (2012) Protective immune responses to biolistic DNA vaccination of Brugia malayi abundant larval transcript-2. Vaccine 30(45):6477–6482
Kanazawa T, Takashima Y et al (2010) Local gene expression and immune responses of vaginal DNA vaccination using a needle-free injector. Int J Pharm 396(1–2):11–16
Kim YC, Quan FS et al (2009) Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine 27(49):6932–6938
Kim YC, Quan FS et al (2010a) Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release 142(2):187–195
Kim YC, Quan FS et al (2010b) Formulation of microneedles coated with influenza virus-like particle vaccine. AAPS PharmSciTech 11(3):1193–1201
Kim YC, Quan FS et al (2010c) Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles. Procedia Vaccinol 2(1):15–19
Kim YC, Quan FS et al (2010d) Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis 201(2):190–198
Kim YC, Quan FS et al (2011) Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res 28(1):135–144
Kim S, Zuiani A et al (2012a) Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection. Vaccine 30(12):2178–2186
Kim YC, Jarrahian C et al (2012b) Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol 351:77–112
Kim YC, Park JH et al (2012c) Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 64(14):1547–1568
Kim YC, Yoo DG et al (2013) Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles. J Control Release 172(2):579–588
Kim NW, Lee MS et al (2014) Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine. J Control Release 179:11–17
Kis EE, Winter G et al (2012) Devices for intradermal vaccination. Vaccine 30(3):523–538
Klein TM, Wolf ED et al (1987) High-velocity microprojectiles for delivering nucleic acids into living cells. Nature 327(6117):70–73
Kok PW, Kenya PR et al (1983) Measles immunization with further attenuated heat-stable measles vaccine using five different methods of administration. Trans R Soc Trop Med Hyg 77(2):171–176
Kommareddy S, Baudner BC et al (2012) Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. J Pharm Sci 101(3):1021–1027
Kondo T, McGregor M et al (2004) A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection. Virology 318(1):414–419
Koutsonanos DG, Vassilieva EV et al (2012) Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection. Sci Rep 2:357
Kumar A, Li X et al (2011) Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin. Int J Nanomedicine 6:1253–1264
Kupper TS, Fuhlbrigge RC (2004) Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol 4(3):211–222
La Montagne JR, Fauci AS (2004) Intradermal influenza vaccination – can less be more? N Engl J Med 351(22):2330–2332
Lambert PH, Laurent PE (2008) Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 26(26):3197–3208
Lambracht-Washington D, Qu BX et al (2009) DNA beta-amyloid(1–42) trimer immunization for Alzheimer disease in a wild-type mouse model. JAMA 302(16):1796–1802
Lambracht-Washington D, Qu BX et al (2011) DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer’s disease as it diminishes antigen-specific Th1 and Th17 cell proliferation. Cell Mol Neurobiol 31(6):867–874
Laurent PE, Bourhy H et al (2010) Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine 28(36):5850–5856
Leroux-Roels I, Vets E et al (2008) Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine 26(51):6614–6619
Loehr BI, Willson P et al (2000) Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle. J Virol 74(13):6077–6086
Maa YF, Ameri M et al (2004) Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application. Pharm Res 21(3):515–523
Madison KC (2003) Barrier function of the skin: “La Raison d’Etre” of the epidermis. J Invest Dermatol 121(2):231–241
Mantoux C (1909) Tuberculin intradermal reactions in the treatment of tuberculosis: intradermal-tuberculation. Comptes Rendus Hebdomadaires Des Seances De L Academie Des Sciences 148:996–998
Matsuo K, Hirobe S et al (2012a) Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza J Control Release 160:495–501
Matsuo K, Yokota Y et al (2012b) A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens. J Control Release 161:10–17
Michinaka Y, Mitragotri S (2011) Delivery of polymeric particles into skin using needle-free liquid jet injectors. J Control Release 153(3):249–254
Mikszta JA, Alarcon JB et al (2002) Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 8(4):415–419
Mikszta JA, Sullivan VJ et al (2005) Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J Infect Dis 191(2):278–288
Mikszta JA, Dekker JP et al (2006) Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun 74(12):6806–6810
Mitragotri S (2005) Immunization without needles. Nat Rev Immunol 5(12):905–916
Mitragotri S (2006) Innovation – current status and future prospects of needle-free liquid jet injectors. Nat Rev Drug Discov 5(7):543–548
Morefield GL, Tammariello RF et al (2008) An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock. J Immune Based Ther Vaccines 6(1):5
Nelson SJ, Adam KL et al (2004) Single use disposable jet injector. US Patent, Antares Pharma, Inc
Nicolas JF, Guy B (2008) Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 7(8):1201–1214
Niederstadt L, Hohn O et al (2012) Stimulation of IgY responses in gene gun immunized laying hens by combined administration of vector DNA coding for the target antigen Botulinum toxin A1 and for avian cytokine adjuvants. J Immunol Methods 382(1–2):58–67
Omori-Urabe Y, Yoshii K et al (2011) Needle-free jet injection of DNA and protein vaccine of the Far-Eastern subtype of tick-borne encephalitis virus induces protective immunity in mice. Microbiol Immunol 55(12):893–897
Osorio JE, Zuleger CL et al (2003) Immune responses to hepatitis B surface antigen following epidermal powder immunization. Immunol Cell Biol 81(1):52–58
Parker V (1984) Jet gun or syringe? A trial of alternative methods of BCG vaccination. Public Health 98(6):315–320
Pearson FE, McNeilly CL et al (2013) Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice. PLoS One 8(7):e67888
Peng S, Monie A et al (2010) Efficient delivery of DNA vaccines using human papillomavirus pseudovirions. Gene Ther 17(12):1453–1464
Pokorna D, Polakova I et al (2009) Vaccination with human papillomavirus type 16-derived peptides using a tattoo device. Vaccine 27(27):3519–3529
Potthoff A, Schwannecke S et al (2009) Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccines. Vaccine 27(21):2768–2774
Qu BX, Rosenberg RN et al (2004) Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Arch Neurol 61(12): 1859–1864
Qu BX, Boyer PJ et al (2006) A beta(42) gene vaccination reduces brain amyloid plaque burden in transgenic mice. J Neurol Sci 244(1–2):151–158
Qu BX, Xiang Q et al (2007) A beta(42) gene vaccine prevents A beta(42) deposition in brain of double transgenic mice. J Neurol Sci 260(1–2):204–213
Qu BX, Lambracht-Washington D et al (2010) Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer’s disease. Vaccine 28(32):5280–5287
Quaak SGL, van den Berg JH et al (2008) GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial. Eur J Pharm Biopharm 70(2):429–438
Quaak SGL, van den Berg JH et al (2009) DNA tattoo vaccination: effect on plasmid purity and transfection efficiency of different topoisoforms. J Control Release 139(2):153–159
Quan FS, Kim YC et al (2010) Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release 147(3):326–332
Quan FS, Kim YC et al (2013) Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch. Clin Vaccine Immunol 20(9):1433–1439
Ren S, Li M et al (2002) Low-volume jet injection for intradermal immunization in rabbits. BMC Biotechnol 2(1):10
Rottinghaus ST, Poland GA et al (2003) Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine 21(31):4604–4608
Roy MJ, Wu MS et al (2001) Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19(7–8):764–778
Sadowski PL, DeBoer DM et al (2003) Needle assited jet injector. US Patent, Antares Pharma, Inc
Scheiblhofer S, Stoecklinger A et al (2007) Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy. Mol Immunol 44(8):1879–1887
Schramm J, Mitragotri S (2002) Transdermal drug delivery by jet injectors: energetics of jet formation and penetration. Pharm Res 19(11):1673–1679
Schramm-Baxter J, Mitragotri S (2004) Needle-free jet injections: dependence of jet penetration and dispersion in the skin on jet power. J Control Release 97(3):527–535
Schramm-Baxter J, Katrencik J et al (2004) Jet injection into polyacrylamide gels: investigation of jet injection mechanics. J Biomech 37(8):1181–1188
Shergold OA, Fleck NA et al (2006) The penetration of a soft solid by a liquid jet, with application to the administration of a needle-free injection. J Biomech 39(14):2593–2602
Simon JK, Carter M et al (2011) Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector. Vaccine 29(51):9544–9550
Smorlesi A, Papalini F et al (2006) Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma. Vaccine 24(11):1766–1775
Stachowiak JC, Li TH et al (2009) Dynamic control of needle-free jet injection. J Control Release 135(2):104–112
Sullivan SP, Koutsonanos DG et al (2010) Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16(8):915–920
Tacket CO, Roy MJ et al (1999) Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 17(22):2826–2829
Trimble C, Lin CT et al (2003) Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 21(25–26):4036–4042
van den Berg JH, Nuijen B et al (2009) Optimization of intradermal vaccination by DNA tattooing in human skin. Hum Gene Ther 20(3):181–189
Verstrepen BE, Bins AD et al (2008) Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates. Vaccine 26(26):3346–3351
Wang SX, Zhang CH et al (2008) The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 26(17):2100–2110
Weiss R, Scheiblhofer S et al (2002) Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 20(25–26):3148–3154
Weiss R, Gabler M et al (2010) Differential effects of C3d on the immunogenicity of gene gun vaccines encoding Plasmodium falciparum and Plasmodium berghei MSP1(42). Vaccine 28(28):4515–4522
Weldon WC, Zarnitsyn VG et al (2012) Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine. PLoS One 7(7):e41501
Weniger BG, Papania MJ (2008) Alternative vaccine delivery methods. In: Plotkin SA, Orenstein WA, Offit P (eds) Vaccines. Saunders Elsevier, Philadelphia, pp 1357–1392
Williams J, Fox-Leyva L et al (2000) Hepatitis A vaccine administration: comparison between jet-injector and needle injection. Vaccine 18(18):1939–1943
Yang NS, Sun WH (1995) Gene gun and other non-viral approaches for cancer gene therapy. Nat Med 1(5):481–483
Yuen C, Liu Q (2015) Hollow agarose microneedle with silver coating for intradermal surface-enhanced Raman measurements: a skin-mimicking phantom study. J Biomed Opt 20(6):61102
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kim, YC. (2017). Skin Vaccination Methods: Gene Gun, Jet Injector, Tattoo Vaccine, and Microneedle. In: Dragicevic, N., I. Maibach, H. (eds) Percutaneous Penetration Enhancers Physical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53273-7_30
Download citation
DOI: https://doi.org/10.1007/978-3-662-53273-7_30
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53271-3
Online ISBN: 978-3-662-53273-7
eBook Packages: MedicineMedicine (R0)